The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Structural determinants of integrin β-subunit specificity for latent TGF-β
Open accessAbstract
Eight integrin α-β heterodimers recognize ligands with an Arg-Gly-Asp (RGD) motif. However, the structural mechanism by which integrins differentiate among extracellular proteins with RGD motifs is not understood. Here, crystal structures, mutations and peptide-affinity measurements show that αVβ6 binds with high affinity to a RGDLXXL/I motif within the prodomains of TGF-β1 and TGF-β3. The LXXL/I motif forms an amphipathic α-helix that binds in a hydrophobic pocket in the β6 subunit. Elucidation of the basis for ligand binding specificity by the integrin β subunit reveals contributions by three different βI-domain loops, which we designate specificity-determining loops (SDLs) 1, 2 and 3. Variation in a pair of single key residues in SDL1 and SDL3 correlates with the variation of the entire β subunit in integrin evolution, thus suggesting a paradigmatic role in overall β-subunit function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“highlighting context dependency of the various αv-containing integrins in the regulation of fibrosis across different organs”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [107]
In the citing paper
“whereas global loss of β3, β5 or β6 integrins or conditional loss of β8 integrins in myofibroblasts did not”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [107]
In the citing paper
“Pharmacological blockade of αv-containing integrins by a small molecule (CWHM 12) attenuated both liver and lung fibrosis, even when fibrosis was already established107”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [107]
In the citing paper
“Using Pdgfrβ-Cre mice to deplete αv integrins on hepatic myofibroblasts protected mice from carbon tetrachloride-induced hepatic fibrosis”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [107]
In the citing paper
“depletion of the αv integrin subunit on mesenchymal cells has also proven effective in inhibiting fibrosis in models of liver, lung and kidney fibrosis107”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I., Leaver‐Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J. S., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,918
International Tables for Crystallography
(2013) · International Tables for Crystallography · doi:10.1107/97809553602060000113 · Cited by 3,833
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Linking Crystallographic Model and Data Quality
Karplus, P. A., & Diederichs, K. (2012) · Science · doi:10.1126/science.1218231 · Cited by 1,781
Xiong, J.-P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., & Arnaout, M. A. (2002) · Science · doi:10.1126/science.1069040 · Cited by 1,617
Cited by
Sorted by citations
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
TGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
The role of integrins in inflammation and angiogenesis
Mezu‐Ndubuisi, O. J., & Maheshwari, A. (2020) · Pediatric Research · doi:10.1038/s41390-020-01177-9 · Cited by 402
Overcoming TGFβ-mediated immune evasion in cancer
Tauriello, D. V. F., Sancho, E., & Batlle, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00413-6 · Cited by 377
Structural Biology and Evolution of the TGF-β FamilyPreprint
Hinck, A. P., Mueller, T. D., & Springer, T. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022103 · Cited by 381
Self-citationTGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
Caja, L., Dituri, F., Mancarella, S., Caballero‐Díaz, D., Moustakas, A., Giannelli, G., & Fabregat, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051294 · Cited by 361
The α v β 1 integrin plays a critical in vivo role in tissue fibrosis
Reed, N. I., Jo, H., Chen, C., Tsujino, K., Arnold, T. D., DeGrado, W. F., & Sheppard, D. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5094 · Cited by 311
Force interacts with macromolecular structure in activation of TGF-β
Dong, X., Zhao, B., Iacob, R. E., Zhu, J., Koksal, A. C., Lu, C., Engen, J. R., & Springer, T. A. (2017) · Nature · doi:10.1038/nature21035 · Cited by 273
Self-citationTargeting TGF-β Signaling for Therapeutic GainPreprint
Akhurst, R. J. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022301 · Cited by 255
Mechanical stress determines the configuration of TGFβ activation in articular cartilage
Zhen, G., Guo, Q., Li, Y., Wu, C., Zhu, S., Wang, R., Guo, X.-D. E., Kim, B. C., Huang, J., Hu, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21948-0 · Cited by 197
Duffy, C., Sorolla, A., Wang, E., Golden, E., Woodward, E., Davern, K. M., Ho, D., Johnstone, E. K. M., Pfleger, K. D. G., Redfern, A. D., et al. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-00129-0 · Cited by 186
Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β
Campbell, M. G., Cormier, A., Ito, S., Seed, R., Bondesson, A. J., Lou, J., Marks, J. D., Baron, J. L., Cheng, Y., & Nishimura, S. L. (2020) · Cell · doi:10.1016/j.cell.2019.12.030 · Cited by 183
Conformational equilibria and intrinsic affinities define integrin activation
Li, J., Su, Y., Xia, W. T., Qin, Y., Humphries, M. J., Vestweber, D., Cabañas, C., Lu, C., & Springer, T. A. (2017) · The EMBO Journal · doi:10.15252/embj.201695803 · Cited by 149
Self-citationAn αv‐RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities
Hatley, R. J. D., Macdonald, S. J. F., Slack, R. J., Le, J., Ludbrook, S. B., & Lukey, P. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707948 · Cited by 132
Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
Brown, N. F., & Marshall, J. F. (2019) · Cancers · doi:10.3390/cancers11091221 · Cited by 116
TGF-β Family Signaling in Connective Tissue and Skeletal DiseasesPreprint
MacFarlane, E. G., Haupt, J., Dietz, H. C., & Shore, E. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022269 · Cited by 125
Structural mechanism of laminin recognition by integrin
Arimori, T., Miyazaki, N., Mihara, E., Takizawa, M., Taniguchi, Y., Cabañas, C., Sekiguchi, K., & Takagi, J. (2021) · Nature Communications · doi:10.1038/s41467-021-24184-8 · Cited by 115
Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8
Stockis, J., Liénart, S., Colau, D., Collignon, A., Nishimura, S. L., Sheppard, D., Coulie, P. G., & Lucas, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710680114 · Cited by 111
Sathiyamoorthy, K., Hu, Y. X., Möhl, B. S., Chen, J., Longnecker, R., & Jardetzky, T. S. (2016) · Nature Communications · doi:10.1038/ncomms13557 · Cited by 113
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
Blandin, A.-F., Renner, G., Lehmann, M., Lelong-Rebel, I. H., Martin, S., & Dontenwill, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00279 · Cited by 105
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
Zhang, J., ten Dijke, P., Wuhrer, M., & Zhang, T. (2020) · Protein & Cell · doi:10.1007/s13238-020-00741-7 · Cited by 101
Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus
Kotecha, A., Wang, Q., Dong, X., Ilca, S. L., Ondiviela, M., Zihe, R., Seago, J. E., Charleston, B., Fry, E. E., Abrescia, N. G. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15408 · Cited by 97
Self-citationTransforming growth factor-β receptors: versatile mechanisms of ligand activation
Chia, Z.-J., Cao, Y., Little, P. J., & Kamato, D. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01235-6 · Cited by 91
Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6‐Selective Integrin Ligands
Maltsev, O. V., Marelli, U. K., Kapp, T. G., Leva, F. S. D., Maro, S. D., Nieberler, M., Reuning, U., Schwaiger, M., Novellino, E., Marinelli, L., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508709 · Cited by 78
αIIbβ3: structure and function
Coller, B. S. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12915 · Cited by 76
Discovery of a new class of integrin antibodies for fibrosis
Zhang, J., Wang, T., Saigal, A., Johnson, J., Morrisson, J., Tabrizifard, S., Hollingsworth, S. A., Eddins, M. J., Mao, W., O’Neill, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81253-0 · Cited by 75
αvβ8 integrin adhesion and signaling pathways in development, physiology and disease
McCarty, J. H. (2020) · Journal of Cell Science · doi:10.1242/jcs.239434 · Cited by 70
Mészáros, B., Sámano‐Sánchez, H., Alvarado-Valverde, J., Čalyševa, J., Martínez‐Pérez, E., Alves, R., Shields, D. C., Kumar, M., Rippmann, F., Chemes, L. B., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abd0334 · Cited by 67
Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
Möhl, B. S., Chen, J., Sathiyamoorthy, K., Jardetzky, T. S., & Longnecker, R. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0066 · Cited by 65
A general chemical principle for creating closure-stabilizing integrin inhibitors
Lin, F., Li, J., Xie, Y., Zhu, J., Nguyen, T. T. H., Zhang, Y., Zhu, J., & Springer, T. A. (2022) · Cell · doi:10.1016/j.cell.2022.08.008 · Cited by 58
Self-citationMészáros, B., Sámano Sánchez, H., Alvarado Valverde, J., Čalyševa, J., Martinez Perez, E., Alves, R., Shields, D. C., Kumar, M., Rippmann, F., Chemes, L. B., et al. (2021) · CONICET Digital (CONICET) · Cited by 59
Dynamic allostery drives autocrine and paracrine TGF-β signaling
Jin, M., Seed, R., Cai, G., Shing, T., Wang, L., Ito, S., Cormier, A., Wankowicz, S. A. M., Jespersen, J. M., Baron, J. L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.036 · Cited by 58
Energy landscape differences among integrins establish the framework for understanding activation
Li, J., & Springer, T. A. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201701169 · Cited by 55
Self-citationDistinct recognition of complement iC3b by integrins α X β 2 and α M β 2
Xu, S., Wang, J., Wang, J., & Springer, T. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620881114 · Cited by 54
Self-citationProdomain–growth factor swapping in the structure of pro-TGF-β1
Zhao, B., Xu, S., Dong, X., Lu, C., & Springer, T. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809657 · Cited by 55
Self-citationMatters of context guide future research in TGFβ superfamily signaling
Akhurst, R. J., & Padgett, R. W. (2015) · Science Signaling · doi:10.1126/scisignal.aad0416 · Cited by 52
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
Brzozowska, E., & Deshmukh, S. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012346 · Cited by 51
Baiula, M., Galletti, P., Martelli, G., Soldati, R., Belvisi, L., Civera, M., Dattoli, S. D., Spampinato, S. M., & Giacomini, D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00576 · Cited by 52
Sorolla, A., Wang, E., Clemons, T. D., Evans, C. W., Plani-Lam, J. H. C., Golden, E., Dessauvagie, B., Redfern, A. D., Swaminathan-Iyer, K., & Blancafort, P. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.04.006 · Cited by 51
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
Roy, A., Shi, L., Chang, A., Dong, X., Fernandez, A. N., Kraft, J. C., Li, J., Le, V. Q., Winegar, R. V., Cherf, G. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41272-z · Cited by 52
Self-citationDundas, K., Shears, M. J., Sun, Y. E., Hopp, C. S., Crosnier, C., Metcalf, T., Girling, G., Sinnis, P., Billker, O., & Wright, G. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719660115 · Cited by 45
Şen, M., & Springer, T. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601379113 · Cited by 42
Self-citationArimori, T., Kitago, Y., Umitsu, M., Fujii, Y., Asaki, R., Tamura‐Kawakami, K., & Takagi, J. (2017) · Structure · doi:10.1016/j.str.2017.08.011 · Cited by 44
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide
Reichart, F., Maltsev, O. V., Kapp, T. G., Räder, A. F. B., Weinmüller, M., Marelli, U. K., Notni, J., Wurzer, A. J., Beck, R., Wester, H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01588 · Cited by 43
Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review
Tvaroška, I., Kozmon, S., & Kóňa, J. (2023) · Cells · doi:10.3390/cells12020324 · Cited by 44
Vishwakarma, P., Parmar, N., Chandrakar, P., Sharma, T., Kathuria, M., Agnihotri, P. K., Siddiqi, M. I., Mitra, K., & Kar, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2653-3 · Cited by 42
From a Helix to a Small Cycle: Metadynamics‐Inspired αvβ6 Integrin Selective Ligands
Leva, F. S. D., Tomassi, S., Maro, S. D., Reichart, F., Notni, J., Dangi, A., Marelli, U. K., Brancaccio, D., Merlino, F., Wester, H., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201803250 · Cited by 42
Molecular Basis of the Ligand Binding Specificity of αvβ8 Integrin
Ozawa, A., Sato, Y., Imabayashi, T., Uemura, T., Takagi, J., & Sekiguchi, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719138 · Cited by 41
Atypical interactions of integrin α V β 8 with pro-TGF-β1
Wang, J., Dong, X., Zhao, B., Li, J., Lu, C., & Springer, T. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705129114 · Cited by 44
Self-citationProcopiou, P. A., Anderson, N. A., Barrett, J., Barrett, T. N., Crawford, M. H. J., Fallon, B. J., Hancock, A. P., Le, J., Lemma, S., Marshall, R. P., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00959 · Cited by 41
Zheng, Y., & Leftheris, K. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01869 · Cited by 40
Low-affinity integrin states have faster ligand-binding kinetics than the high-affinity state
Li, J., Yan, J., & Springer, T. A. (2021) · eLife · doi:10.7554/elife.73359 · Cited by 39
Self-citationAn engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species
Hong, A. V., Suel, L., Petat, E., Dubois, A., Brun, P., Guerchet, N., Veron, P., Poupiot, J., & Richard, I. (2024) · Nature Communications · doi:10.1038/s41467-024-52002-4 · Cited by 43
General structural features that regulate integrin affinity revealed by atypical αVβ8
Wang, J., Su, Y., Iacob, R. E., Engen, J. R., & Springer, T. A. (2019) · Nature Communications · doi:10.1038/s41467-019-13248-5 · Cited by 37
Self-citationCao, Y., Su, H., Zeng, J., Xie, Y., Liu, Z., Liu, F., Qiu, Y., Yi, F., Lin, J., Hammes, H., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.10.007 · Cited by 36
Polymerizing laminins in development, health, and disease
Yurchenco, P. D., & Kulczyk, A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107429 · Cited by 35
Cross-Talk between the TGF-β and Cell Adhesion Signaling Pathways in Cancer
Liao, J., Chen, R., Lin, B., Deng, R., Liang, Y., Zeng, J., Ma, S., & Qiu, X. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.96274 · Cited by 38
Bonsor, D. A., Pham, K. T., Beadenkopf, R., Diederichs, K., Haas, R., Beckett, D., Fischer, W. H., & Sundberg, E. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641829 · Cited by 33
Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment
Sorolla, A., Sorolla, M. A., Wang, E., & Ceña, V. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1814733 · Cited by 31
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
Zhang, Z., Wang, Z., Liu, T., Tang, J., Liu, Y., Gou, T., Chen, K., Wang, L., Zhang, J., Yang, Y., et al. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01921-6 · Cited by 31
Lemay, S.-E. S., Montesinos, M. S., Grobs, Y., Yokokawa, T., Shimauchi, T., Mougin, M., Romanet, C., Sauvaget, M., Breuils‐Bonnet, S., Bourgeois, A., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.070693 · Cited by 31
Specificity of TGF-β1 signal designated by LRRC33 and integrin αVβ8
Duan, Z., Lin, X., Wang, L., Zhen, Q., Jiang, Y., Chen, C., Yang, J. H., Lee, C., Qin, Y., Li, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32655-9 · Cited by 31
Thinn, A. M. M., Wang, Z., Zhou, D., Zhao, Y., Curtis, B. R., & Zhu, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806205115 · Cited by 29
TGFβ: Signaling Blockade for Cancer Immunotherapy
Chen, S., Mamaï, O., & Akhurst, R. J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070620-103554 · Cited by 29
D’Amore, V. M., Donati, G., Lenci, E., Ludwig, B. S., Kossatz, S., Baiula, M., Trabocchi, A., Kessler, H., Leva, F. S. D., & Marinelli, L. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01071 · Cited by 27
Barden, S., & Niemann, H. H. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.01.006 · Cited by 27
Characterisation of a novel, high affinity and selective αvβ6 integrin RGD-mimetic radioligand
Hall, E. R., Bibby, L. I., & Slack, R. J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.003 · Cited by 27
Yokosaki, Y., & Nishimichi, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312794 · Cited by 24
Active Search for Computer‐aided Drug Design
Oglić, D., Oatley, S. A., Macdonald, S. J. F., Mcinally, T., Garnett, R., Hirst, J. D., & Gärtner, T. (2018) · Molecular Informatics · doi:10.1002/minf.201700130 · Cited by 24
Ajmal, M., Yunus, U., Graham, R. M., & Leblanc, R. M. (2019) · ACS Omega · doi:10.1021/acsomega.9b01903 · Cited by 24
Kapp, T. G., Leva, F. S. D., Notni, J., Räder, A. F. B., Fottner, M., Reichart, F., Reich, D., Wurzer, A. J., Steiger, K., Novellino, E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01752 · Cited by 24
De, A., Morales, J. E., Chen, Z., Sebastian, S., & McCarty, J. H. (2022) · Development · doi:10.1242/dev.200472 · Cited by 21
Extracellular citrullination inhibits the function of matrix associated TGF-β
Sipilä, K. H., Ranga, V., Rappu, P., Torittu, A., Pirilä, L., Käpylä, J., Johnson, M. S., Larjava, H., & Heino, J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.02.008 · Cited by 24
Civera, M., Arosio, D., Bonato, F., Manzoni, L., Pignataro, L., Zanella, S., Gennari, C., Piarulli, U., & Belvisi, L. (2017) · Cancers · doi:10.3390/cancers9100128 · Cited by 23
Godwin, A. R. F., Dajani, R., Zhang, X., Thomson, J., Holmes, D. F., Adamo, C. S., Sengle, G., Sherratt, M. J., Roseman, A. M., & Baldock, C. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00950-8 · Cited by 22
Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex
Nes̆ić, D., Zhang, Y., Spasic, A., Li, J., Provasi, D., Filizola, M., Walz, T., & Coller, B. S. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313671 · Cited by 22
A specialized integrin-binding motif enables proTGF-β2 activation by integrin αVβ6 but not αVβ8
Le, V. Q., Zhao, B., Ramesh, S., Toohey, C., DeCosta, A., Mintseris, J., Liu, X., Gygi, S. P., & Springer, T. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304874120 · Cited by 23
Self-citationHigh integrin α V β 6 affinity reached by hybrid domain deletion slows ligand-binding on-rate
Dong, X., Zhao, B., Lin, F., Lu, C., Rogers, B. N., & Springer, T. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718662115 · Cited by 22
Self-citationBuß, M., Tegtmeyer, N., Schnieder, J., Dong, X., Li, J., Springer, T. A., Backert, S., & Niemann, H. H. (2019) · FEBS Journal · doi:10.1111/febs.14962 · Cited by 20
Self-citationZafar, H., Shang, Y., Li, J., David, G., Fernandez, J., Molina, H., Filizola, M., & Coller, B. S. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017004689 · Cited by 19
Woodward, E., Wang, E., Wallis, C. J. D., Sharma, R. K., Tie, A. W. J., Murthy, N., & Blancafort, P. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4051-7_14 · Cited by 18
The RGD-binding integrins αvβ6 and αvβ8 are receptors for mouse adenovirus-1 and -3 infection
Bieri, M., Hendrickx, R., Bauer, M., Yu, B., Jetzer, T., Dreier, B., Mittl, P. R. E., Sobek, J., Plückthun, A., Greber, U. F., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010083 · Cited by 18
Li, B., Fu, Q., Lu, Y. Z., Chen, C., Zhao, Y., Zhao, Y., Cao, M., Zhou, W., Fan, X., Jiang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60062-3 · Cited by 19
Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis
Bellani, S., Molyneaux, P. L., Maher, T. M., & Spagnolo, P. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2375375 · Cited by 16
Robinson, H., Oatley, S. A., Rowedder, J. E., Slade, P., Macdonald, S. J. F., Argent, S. P., Hirst, J. D., McInally, T., & Moody, C. J. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001059 · Cited by 15
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes
Floresta, G., Memdouh, S., Pham, T., Ma, M., Blower, P. J., Hider, R. C., Abbate, V., & Cilibrizzi, A. (2022) · Dalton Transactions · doi:10.1039/d2dt00980c · Cited by 15
Li, F., Wu, S., Lv, L., Huang, S., Zhang, Z., Zerang, Z., Li, P., Cao, Y., Bao, H., Sun, P., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012623 · Cited by 14
Lin, X., Yang, Y., Song, Y., Li, S., Zhang, X., Su, Z. G., & Zhang, S. (2021) · Journal of Virology · doi:10.1128/jvi.02431-20 · Cited by 13
Takahashi, M., Hashimoto, Y., & Nakamura, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.001 · Cited by 13
Family-wide analysis of integrin structures predicted by AlphaFold2
Zhang, H., Zhu, D. S., & Zhu, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.09.022 · Cited by 12
Brown, N. F., Murray, E. R., Cutmore, L. C., Howard, P. W., Masterson, L. A., Zammarchi, F., Hartley, J. A., van Berkel, P. H., & Marshall, J. F. (2024) · Pancreatology · doi:10.1016/j.pan.2024.02.013 · Cited by 12
Hatley, R. J. D., Macdonald, S. J. F., Slack, R. J., Le, J., Ludbrook, S. B., & Lukey, P. T. (2017) · Angewandte Chemie · doi:10.1002/ange.201707948 · Cited by 13
Tang, Y. C., Davis, R. A., Ganguly, T., & Sutcliffe-Goulden, J. (2019) · Molecules · doi:10.3390/molecules24020309 · Cited by 12
Stabile Peptide statt “gestapelte Peptide”: hochaffine αvβ6‐selektive Integrinliganden
Maltsev, O. V., Marelli, U. K., Kapp, T. G., Leva, F. S. D., Maro, S. D., Nieberler, M., Reuning, U., Schwaiger, M., Novellino, E., Marinelli, L., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201508709 · Cited by 12
Structural analysis of peptide binding to integrins for cancer detection and treatment
Urquiza, M., Benavides-Rubio, D., & Jimenez-Camacho, S. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01084-3 · Cited by 12
Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma
Müller, M., Altmann, A., Sauter, M., Lindner, T., Jäger, D., Rathke, H. G., Herold‐Mende, C. C., Marmé, F., Babich, J. W., Mier, W., et al. (2019) · Nuklearmedizin - NuclearMedicine · doi:10.1055/a-0894-4127 · Cited by 11
Macdonald, S. J. F., Fray, M. J., & McInally, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.015 · Cited by 11
Weil, P. P., van den Bruck, R., Ziegenhals, T., Juranek, S., Goedde, D., Orth, V., Wirth, S., Jenke, A. C. W., & Postberg, J. (2019) · Gut · doi:10.1136/gutjnl-2019-319015 · Cited by 11
Hao, Y., Yan, J., Fraser, C., Jiang, A., Anuganti, M., Zhang, R., Lloyd, K., Jardine, J. G., Coppola, J. D., Meijers, R., et al. (2024) · mAbs · doi:10.1080/19420862.2024.2365891 · Cited by 9
Self-citationDeb, V. K., & Jain, U. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147121 · Cited by 11
Metadata
- Authors
- Dong, X., Hudson, N. E., Lu, C., & Springer, T. A.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Springer, Timothy A
- Venue
- Nature Structural & Molecular Biology
- Published
- 2014-11-10
- Volume
- 21
- Issue
- 12
- Pages
- 1091-1096
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- PMC
- PMC4717663
- OpenAlex
- W2017269651
- Cited by
- 141
- References
- 40
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 13 · 2023: 13 · 2022: 8 · 2021: 14 · 2020: 17 · 2019: 13 · 2018: 9 · 2017: 17 · 2016: 10 · 2015: 8
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL103526)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ6, latent TGF-beta1, RGD motif, ligand specificity, amphipathic helix, hydrophobic pocket
- MeSH terms
- Amino Acid Sequence, Antigens, Neoplasm, Binding Sites, Humans, Models, Molecular, Molecular Sequence Data, Mutation, Integrins, Sequence Alignment, Crystallography, X-Ray, Transforming Growth Factor beta1, Transforming Growth Factor beta3, Protein Interaction Domains and Motifs, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review